EFFECT OF ADP-RIBOSYLATION OF p33 AND ACTIN ON POLYMORPHONUCLEAR LEUKOCYTE DIFFERENTIATION

p33 和肌动蛋白 ADP 核糖基化对多形核白细胞分化的影响

基本信息

  • 批准号:
    06807011
  • 负责人:
  • 金额:
    $ 1.28万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

By the support of the Grant-in-Aid for Scientific Research 0680711, we obtained the following results. 1) Arginine-specific ADP-ribosyltransferase from chicken heterophils ADP-ribosylated Arg-28 and Arg-206 of G-actin, and Arg-28 of F-actin in vitro, without affecting the ATPase activity, indicating the modification of Arg-206 prevents the polymerization of actin. 2) Arginine-specific ADP-ribosyltransferase from chicken heterophils ADP-ribosylated Arg-113, Arg-250 and Arg-254 of p33 in vitro. Though 4 mol of ADP-ribose can be stoichiometrically incorporated into one mol of p33, besides these three arginine residues, five candidates (Arg-8, Arg-37, Arg-235, Arg-269, and Arg-285) were detected. Partial reduction of intramolecular disulfide bonds of p33 by sulfhydryl agent, necessary for the ADP-ribosylation, may play a role to change the conformation of the p33 and accessibility of the transferase. 3) Amino terminal sequence of p33-half-2 was SPPFPQQ,indicating that the cleavage site is upstream of Ser-149 in the spacer region of p33.4) cDNA cloning revealed that chicken bone marrow cells have at least two ADP-ribosyltransferases. 5) Enzyme activity or expression of the transferase and amount of the protein or message of p33 found in peripheral polymorphonuclear leukocytes were lower than one tenth of those detected in bone marrow cells.Though we established the method to detect p33 and p33-halves using anti-p33 antibodies, we have not yet demonstrated the activity of endopeptidase which specifically cleaves p33 and generates p33-halves, in vitro or in reconstituting system. Further studies are required to identify the endopeptidase and elucidate its importance.
在科学研究助学金0680711的支持下,我们取得了以下成果。1)ADP-核糖基转移酶体外结合了G-肌动蛋白的Arg-28和Arg-206,F-肌动蛋白的Arg-28,而不影响ATPase的活性,表明Arg-206的修饰阻止了肌动蛋白的聚合。2)鸡嗜异体精氨酸特异性ADP-核糖基转移酶体外作用于p33的Arg-113、Arg-250和Arg-254。虽然4摩尔的ADP-核糖可以化学计量地掺入1摩尔的p33中,但除了这3个精氨酸残基外,还检测到5个候选残基(Arg-8、Arg-37、Arg-235、Arg-269和Arg-285)。ADP-核糖化所必需的分子内二硫键被巯基试剂部分还原,可能会改变p33的构象和转移酶的可及性。3)p33-Half-2的氨基末端序列为SPPFPQQ,表明其切割位点位于p33.4间隔区Ser-149上游。5)外周血多形核白细胞中p33的酶活性或转移酶的表达及蛋白或信息量低于骨髓细胞的十分之一。虽然我们建立了用抗p33抗体检测p33和p33-Half的方法,但我们尚未在体外或重组系统中证明特异性切割p33并产生p33-Half的内肽酶的活性。需要进一步的研究来鉴定内肽酶并阐明其重要性。

项目成果

期刊论文数量(76)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Jose L.Rosa: "Role of the NH2-terminal region in covalent modification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase" Biochem.J.(印刷中). (1995)
Jose L. Rosa:“NH2 末端区域在 6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶共价修饰中的作用”Biochem.J(出版中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tsuyoshi Miyaoka: "Activation of Clostridium botulinum C3 exoenzyme-catalyzed ADP-ribosylation of RhoA by K^+ in a Mg^<2+> -dependent manner" J. Biochem.119. 200-207 (1996)
Tsuyoshi Miyaoka:“K ^ 以Mg ^ 2 依赖性方式激活肉毒杆菌C3外切酶催化的RhoA的ADP核糖基化”J.Biochem.119。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Mikako Tsuchiya: "Cloning and expression of cDNA for arginine-specific ADP-ribosyltransferase from chicken bone marrow cells" J.Biol.Chem.269-44. 27451-27457 (1994)
Mikako Tsuchiya:“鸡骨髓细胞精氨酸特异性 ADP-核糖基转移酶 cDNA 的克隆和表达”J.Biol.Chem.269-44。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masaharu Terashima: "ADP-ribosylation of Arg28 and Arg206 on the actin molecule by chicken arginine-specific ADP-ribosyltransferase" Eur.J.Biochem.231-1. 242-249 (1995)
Masaharu Terashima:“鸡精氨酸特异性 ADP-核糖基转移酶对肌动蛋白分子上的 Arg28 和 Arg206 进行 ADP-核糖基化”Eur.J.Biochem.231-1。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Cikako Yamamori: "ADP-ribosylation of myelin basic protein and inhibition of phospholipid vesicle aggregation" Enzyme Protein. 48. 202-212 (1994)
Cikako Yamamori:“髓磷脂碱性蛋白的 ADP-核糖基化和磷脂囊泡聚集的抑制”酶蛋白。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIMOYAMA Makoto其他文献

Real world data of first line treatment with pembrolizumab for highly PD L1 expressing NSCLC
使用派姆单抗一线治疗高 PD L1 表达 NSCLC 的真实世界数据
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    KAZAMA Itsuro;KUWANA Ryo;MUTO Mizuki;NAGANO Amu;FUJIMURA Ririka;ASADA Ayano;TAMADA Tsutomu;SHIMOYAMA Makoto;Maki Kobayashi
  • 通讯作者:
    Maki Kobayashi

SHIMOYAMA Makoto的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIMOYAMA Makoto', 18)}}的其他基金

Development of a novel tele-nursing support program using visualization of physical activity for the patients with chronic respiratory failure
为慢性呼吸衰竭患者开发一种新型远程护理支持计划,利用体力活动可视化
  • 批准号:
    16K20757
  • 财政年份:
    2016
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
ADP-ribosylation of p33 (mim-1 protein) and its effect on differentiation and growth of blood cells
p33(mim-1蛋白)的ADP-核糖基化及其对血细胞分化和生长的影响
  • 批准号:
    04807016
  • 财政年份:
    1992
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
ADP-Ribosylation Reaction in Rabbit Skeletal Muscle SR
兔骨骼肌 SR 中的 ADP-核糖基化反应
  • 批准号:
    01580192
  • 财政年份:
    1989
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Assessing the interplay between the mono-ADP-ribosyltransferase ARTD10 and the Chikungunya viral macrodomain in modulating the antiviral immune response.
评估单 ADP-核糖基转移酶 ARTD10 和基孔肯雅病毒大结构域在调节抗病毒免疫反应中的相互作用。
  • 批准号:
    401204753
  • 财政年份:
    2018
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Research Grants
Two kinds of specificities essential for mono-ADP-ribosyltransferase reaction.
单 ADP 核糖基转移酶反应必需的两种特异性。
  • 批准号:
    17K15095
  • 财政年份:
    2017
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Characterization of novel ADP-ribosyltransferase toxin from Salmonella which cause Salmonellosis in adult cattle.
来自引起成年牛沙门氏菌病的沙门氏菌的新型 ADP-核糖基转移酶毒素的表征。
  • 批准号:
    25450434
  • 财政年份:
    2013
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterization of citrin: a novel mono-ADP-ribosyltransferase from Citrobacter rodentium
柠檬酸的表征:来自啮齿类柠檬酸杆菌的新型单 ADP 核糖基转移酶
  • 批准号:
    425591-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Crystallization of mono-ADP-ribosyltransferase (mART) from Enterococcus faecalis V583
来自粪肠球菌 V583 的单 ADP-核糖基转移酶 (mART) 的结晶
  • 批准号:
    397218-2010
  • 财政年份:
    2010
  • 资助金额:
    $ 1.28万
  • 项目类别:
    University Undergraduate Student Research Awards
Analysis of human cell death mechanism caused by ADP-ribosyltransferase Cholix toxin
ADP-核糖基转移酶Cholix毒素引起的人体细胞死亡机制分析
  • 批准号:
    22790401
  • 财政年份:
    2010
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Suppression of innate immunity by an ADP-ribosyltransferase type III effector
ADP-核糖基转移酶 III 型效应子对先天免疫的抑制
  • 批准号:
    7751271
  • 财政年份:
    2007
  • 资助金额:
    $ 1.28万
  • 项目类别:
Suppression of innate immunity by an ADP-ribosyltransferase type III effector
ADP-核糖基转移酶 III 型效应子对先天免疫的抑制
  • 批准号:
    7994822
  • 财政年份:
    2007
  • 资助金额:
    $ 1.28万
  • 项目类别:
Suppression of innate immunity by an ADP-ribosyltransferase type III effector
ADP-核糖基转移酶 III 型效应子对先天免疫的抑制
  • 批准号:
    8197564
  • 财政年份:
    2007
  • 资助金额:
    $ 1.28万
  • 项目类别:
Suppression of innate immunity by an ADP-ribosyltransferase type III effector
ADP-核糖基转移酶 III 型效应子对先天免疫的抑制
  • 批准号:
    7538341
  • 财政年份:
    2007
  • 资助金额:
    $ 1.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了